Walleye Capital’s Surmodics SRDX Stock Holding History

Walleye Capital’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-19,949	Closed	-$625K	–	5310
2023 Q2	$625K	Buy	19,949 +3,959	+25%	+$90.3K	﹤0.01%	2259
2023 Q1	$364K	Buy	+15,990	New	+$412K	0.01%	1964

Other funds holding SRDX

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Walleye Capital's SRDX Position: Q3 2023 in Review

Walleye Capital sold out of Surmodics (SRDX) in Q3 2023, closing a stake of 19,949 shares — an estimated $625K sold.

Walleye Capital first reported a position in SRDX in Q1 2023 and held it in 2 quarters. The position peaked at $625K in Q2 2023. 103 funds tracked by Wall St. Rank hold SRDX as of Q3 2023.

Walleye Capital reported no remaining Surmodics position as of Q3 2023 after selling out during the quarter.
Walleye Capital sold 19,949 Surmodics shares in Q3 2023, an estimated $625K.
Walleye Capital first reported a position in Surmodics in Q1 2023 and held it in 2 quarters.
Walleye Capital's Surmodics position peaked at $625K in Q2 2023.
103 funds tracked by Wall St. Rank held Surmodics as of Q3 2023.

Based on Walleye Capital's 13F filing for Q3 2023, filed 14 Nov 2023.